169 related articles for article (PubMed ID: 19891787)
1. Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.
Hartman J; Lam EW; Gustafsson JA; Ström A
Breast Cancer Res; 2009; 11(6):R79. PubMed ID: 19891787
[TBL] [Abstract][Full Text] [Related]
2. HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1.
Hartman J; Müller P; Foster JS; Wimalasena J; Gustafsson JA; Ström A
Oncogene; 2004 Nov; 23(54):8826-33. PubMed ID: 15467735
[TBL] [Abstract][Full Text] [Related]
3. The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17beta-estradiol on breast cancer cell lines.
Ström A; Arai N; Leers J; Gustafsson JA
Oncogene; 2000 Nov; 19(51):5951-3. PubMed ID: 11127827
[TBL] [Abstract][Full Text] [Related]
4. 17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells.
Belkaid A; Duguay SR; Ouellette RJ; Surette ME
BMC Cancer; 2015 May; 15():440. PubMed ID: 26022099
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
[TBL] [Abstract][Full Text] [Related]
7. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
Meng Y; Gu C; Wu Z; Zhao Y; Si Y; Fu X; Han W
BMC Cancer; 2009 Mar; 9():75. PubMed ID: 19257909
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-dependent downregulation of hairy and enhancer of split homolog-1 gene expression in breast cancer cells is mediated via a 3' distal element.
Müller P; Merrell KW; Crofts JD; Rönnlund C; Lin CY; Gustafsson JA; Ström A
J Endocrinol; 2009 Mar; 200(3):311-9. PubMed ID: 19039095
[TBL] [Abstract][Full Text] [Related]
10. Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Horm Cancer; 2012 Aug; 3(4):147-59. PubMed ID: 22476979
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
Peng J; Jordan VC
Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol AF stimulates transcription and secretion of C-X-C chemokine ligand 12 to promote proliferation of cultured T47D breast cancer cells.
Li M; Han X; Gao W; Chen F; Shao B
Toxicology; 2015 Dec; 338():30-6. PubMed ID: 26435001
[TBL] [Abstract][Full Text] [Related]
16. The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression.
Muller P; Kietz S; Gustafsson JA; Strom A
J Biol Chem; 2002 Aug; 277(32):28376-9. PubMed ID: 12080040
[TBL] [Abstract][Full Text] [Related]
17. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
18. HES-1, a novel target gene for the aryl hydrocarbon receptor.
Thomsen JS; Kietz S; Ström A; Gustafsson JA
Mol Pharmacol; 2004 Jan; 65(1):165-71. PubMed ID: 14722248
[TBL] [Abstract][Full Text] [Related]
19. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
20. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
Müller P; Crofts JD; Newman BS; Bridgewater LC; Lin CY; Gustafsson JA; Ström A
Breast Cancer Res Treat; 2010 Apr; 120(2):317-26. PubMed ID: 19322650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
